Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)

View source ↗

Summary

This clinical trial update describes the BE-FREE study evaluating the effectiveness of eptinezumab when administered during a migraine attack; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VYEPTI (eptinezumab)

Snippet

Sponsor: University of Florence | Conditions: Migraine | Status: RECRUITING